Dawei Chen
104Patents
21h-index
95Co-inventors
93Inventor score
Filing activity: Oct 6, 1998 → Aug 20, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6412478B1 | Breather for internal combustion engine | Mechanical Engineering; Lighting; Heating | 36 | Expired |
| US6068017A | Dual-fuel valve | Emerging Cross-Sectional Technologies | 27 | Expired |
| US9598446B2 | Amino compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 24 | Active |
| US9695205B2 | Amide compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 24 | Active |
| US9663543B2 | Phosphonate compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 24 | Active |
| US9796741B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 24 | Active |
| US10550140B2 | Ether compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 23 | Active |
| US10138225B2 | Amide compounds for treatment of medical disorders | Chemistry; Metallurgy | 23 | Active |
| US9732104B2 | Ether compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 22 | Active |
| US10106563B2 | Ether compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 22 | Active |
| US9732103B2 | Carbamate, ester, and ketone compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 22 | Active |
| US10005802B2 | Amide compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10301336B2 | Phosphonate compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10081645B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10385097B2 | Ether compounds for treatment of medical disorders | Chemistry; Metallurgy | 21 | Active |
| US10370394B2 | Carbamate, ester, and ketone compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10287301B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | Emerging Cross-Sectional Technologies | 21 | Active |
| US10000516B2 | Phosphonate compounds for treatment of medical disorders | Chemistry; Metallurgy | 21 | Active |
| US9828396B2 | Alkyne compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10011612B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | Emerging Cross-Sectional Technologies | 21 | Active |
| US10189869B2 | Amino compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10100072B2 | Phosphonate compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 21 | Active |
| US10087203B2 | Compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 20 | Active |
| US10428094B2 | Amide compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 20 | Active |
| US10253053B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | Chemistry; Metallurgy | 20 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.